 Melissa New
Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemoptysis | 2 | 2023 | 35 | 1.100 |
Why?
| | Lung Neoplasms | 8 | 2023 | 2201 | 0.990 |
Why?
| | Epoprostenol | 3 | 2018 | 133 | 0.850 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2023 | 25 | 0.840 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2023 | 26 | 0.840 |
Why?
| | Simulation Training | 1 | 2023 | 62 | 0.820 |
Why?
| | Education, Medical | 1 | 2023 | 221 | 0.720 |
Why?
| | Anticarcinogenic Agents | 1 | 2018 | 67 | 0.600 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 167 | 0.560 |
Why?
| | Physicians | 1 | 2023 | 772 | 0.500 |
Why?
| | Early Detection of Cancer | 3 | 2021 | 339 | 0.410 |
Why?
| | Neoplasms, Experimental | 2 | 2018 | 151 | 0.280 |
Why?
| | Clinical Competence | 2 | 2023 | 899 | 0.280 |
Why?
| | Smoke | 2 | 2018 | 127 | 0.260 |
Why?
| | Telerehabilitation | 1 | 2023 | 29 | 0.210 |
Why?
| | Equipment Design | 1 | 2023 | 513 | 0.190 |
Why?
| | Iloprost | 2 | 2018 | 46 | 0.190 |
Why?
| | Carcinogens | 2 | 2018 | 105 | 0.180 |
Why?
| | Bronchi | 2 | 2018 | 243 | 0.170 |
Why?
| | Cancer Survivors | 1 | 2023 | 204 | 0.170 |
Why?
| | Computer Simulation | 1 | 2023 | 880 | 0.170 |
Why?
| | Mice, Transgenic | 3 | 2018 | 1955 | 0.160 |
Why?
| | Tobacco Smoking | 1 | 2018 | 21 | 0.160 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2018 | 57 | 0.150 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2018 | 108 | 0.150 |
Why?
| | Reminder Systems | 1 | 2019 | 161 | 0.150 |
Why?
| | Curriculum | 1 | 2023 | 843 | 0.140 |
Why?
| | Frizzled Receptors | 1 | 2016 | 22 | 0.130 |
Why?
| | Models, Statistical | 1 | 2020 | 602 | 0.130 |
Why?
| | Patient Compliance | 1 | 2019 | 524 | 0.130 |
Why?
| | Epithelial Cells | 2 | 2018 | 956 | 0.130 |
Why?
| | Telemedicine | 1 | 2023 | 665 | 0.120 |
Why?
| | Health Personnel | 1 | 2020 | 574 | 0.120 |
Why?
| | Humans | 10 | 2023 | 115042 | 0.120 |
Why?
| | Antihypertensive Agents | 1 | 2017 | 430 | 0.110 |
Why?
| | Cohort Studies | 1 | 2023 | 4904 | 0.110 |
Why?
| | Cell Line | 1 | 2018 | 2645 | 0.100 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1398 | 0.100 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 4631 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1184 | 0.100 |
Why?
| | Prospective Studies | 1 | 2023 | 6232 | 0.100 |
Why?
| | Adenocarcinoma | 1 | 2017 | 795 | 0.090 |
Why?
| | MicroRNAs | 1 | 2016 | 603 | 0.090 |
Why?
| | Risk Factors | 1 | 2023 | 8642 | 0.080 |
Why?
| | Biomarkers | 1 | 2018 | 3419 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2018 | 9122 | 0.070 |
Why?
| | Mice | 3 | 2018 | 14927 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2329 | 0.070 |
Why?
| | Urethane | 2 | 2017 | 41 | 0.070 |
Why?
| | Animals | 3 | 2018 | 31867 | 0.050 |
Why?
| | Lung | 2 | 2023 | 3595 | 0.040 |
Why?
| | Aged | 3 | 2021 | 19119 | 0.040 |
Why?
| | Receptors, Prostaglandin | 1 | 2017 | 22 | 0.040 |
Why?
| | Biological Availability | 1 | 2017 | 119 | 0.040 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 78 | 0.040 |
Why?
| | Medicaid | 1 | 2021 | 409 | 0.040 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2017 | 165 | 0.030 |
Why?
| | Middle Aged | 3 | 2021 | 26827 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 666 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2020 | 633 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2021 | 12547 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3334 | 0.030 |
Why?
| | Smoking | 1 | 2019 | 1392 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4420 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 2715 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2191 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2341 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4089 | 0.020 |
Why?
| | Female | 3 | 2020 | 59613 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 3896 | 0.020 |
Why?
| | United States | 1 | 2021 | 12226 | 0.020 |
Why?
| | Male | 2 | 2020 | 55731 | 0.010 |
Why?
|
|
New's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|